Ye J, Xu R H, Taylor-Papadimitriou J, Pitha P M
Oncology Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Mol Cell Biol. 1996 Nov;16(11):6178-89. doi: 10.1128/MCB.16.11.6178.
The human alpha2-integrin gene is transcriptionally downregulated in a nontumorigenic human mammary epithelial cell line, MTSV1-7, and its clonal variant HB2, overexpressing the Erb-B2 oncogene. In this study, we have used deletion mutations within the alpha2-integrin promoter inserted 5' of the chloramphenicol acetyltransferase or luciferase reporter genes to identify the element that is responsible for the Erb-B2-mediated downregulation. The results of the transient-transfection assay showed that the Sp1 binding element located in the core region (positions --64 to +1) of the alpha2-integrin promoter plays an essential role in the alpha2-integrin promoter activity and its downregulation by Erb-B2. By gel shift assay, we have demonstrated that this element binds with a high degree of affinity not only to Sp1, but also to Sp3. The downregulation of the alpha2-integrin promoter activity could also be achieved by overexpression of v-Hras (v-ras), suggesting that the signals generated by Erb-B2, which lead to downregulation of the alpha2-integrin gene expression, may proceed through the ras pathway. Both the Erb-B2- and the v-ras-overexpressing cells exhibited a Sp1 DNA binding activity lower than that of the parental line, while the relative levels of Sp1 protein in these cells were not altered. The Erb-B2- and v-ras-mediated downregulation could be reversed by the overexpression of Sp1 and by a dominant negative variant of ras (rasN17), confirming the importance of Sp1 and the ras pathway. The inhibitory effects of Erb-B2 on transcriptional activity of the alpha2-integrin promoter were observed in transient-cotransfection assays using alpha2-integrin reporter plasmids and plasmids expressing the Erb-B2 or v-ras oncogene. The same effects were seen when an alpha2-integrin reporter gene construct was transfected into MTSV1-7 or HB2 cells permanently overexpressing Erb-B2 or v-ras. The effects of Erb-B2 or v-ras on the transcriptional activity of the alpha2-integrin promoter were observed in nontumorigenic luminal epithelial cell lines (MTSV1-7 and HB2) as well as in the breast cancer cell line T47D. These data suggest that in luminal epithelial cells and the breast cancers which develop from them, the Erb-B2 proto-oncogene signaling leads to inhibition of (alpha)2(beta)1-integrin gene expression and could contribute to the disruption of tissue architecture seen in breast cancers.
人类α2整合素基因在非致瘤性人乳腺上皮细胞系MTSV1-7及其过表达Erb-B2癌基因的克隆变体HB2中发生转录下调。在本研究中,我们利用插入氯霉素乙酰转移酶或荧光素酶报告基因5'端的α2整合素启动子内的缺失突变,来鉴定负责Erb-B2介导的下调的元件。瞬时转染分析结果表明,位于α2整合素启动子核心区域(位置-64至+1)的Sp1结合元件在α2整合素启动子活性及其被Erb-B2下调中起关键作用。通过凝胶迁移分析,我们证明该元件不仅与Sp1,而且与Sp3具有高度亲和力结合。α2整合素启动子活性的下调也可通过v-Hras(v-ras)的过表达来实现,这表明由Erb-B2产生的导致α2整合素基因表达下调的信号可能通过ras途径进行。过表达Erb-B2和v-ras的细胞均表现出低于亲代细胞系的Sp1 DNA结合活性,而这些细胞中Sp1蛋白的相对水平未改变。Sp1的过表达和ras的显性负变体(rasN17)可逆转Erb-B2和v-ras介导的下调,证实了Sp1和ras途径的重要性。在使用α2整合素报告质粒和表达Erb-B2或v-ras癌基因的质粒的瞬时共转染分析中,观察到Erb-B2对α2整合素启动子转录活性的抑制作用。当将α2整合素报告基因构建体转染到永久过表达Erb-B2或v-ras的MTSV1-7或HB2细胞中时,也观察到相同的效果。在非致瘤性腔上皮细胞系(MTSV1-7和HB2)以及乳腺癌细胞系T47D中,观察到了Erb-B2或v-ras对α2整合素启动子转录活性的影响。这些数据表明,在腔上皮细胞及其衍生的乳腺癌中,Erb-B2原癌基因信号传导导致抑制(α)2(β)1整合素基因表达,并可能导致乳腺癌中所见的组织结构破坏。